Physician profile
Prity S Vaidya
NPI 1003874090
$2,810.89
in general payments reported to CMS, 2019-2025
11 companies · $2,378 in 2025
The $2,378 reported for 2025 was more than what 87% of Infectious Disease providers received nationally (typical 2025 total: $187).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $104 · 2021: $80.46 · 2024: $248 · 2025: $2,378.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,598 · Food and Beverage: $1,028.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,597.66 |
| Food and Beverage | $1,028.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mimedx Group, INC. | $1,630.66 | 2024-2025 | |
| Kerecis Limited | $586.78 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Smith+Nephew, INC. | $121.46 | 2024-2025 | Grafix Pl, Allevyn Life L 15.4x15.4 Ctn10, Profore Kit Lf Ankle Circ 18-25cm Case 8 |
| Glaxosmithkline, LLC. | $104.44 | 2019 | |
| Shionogi INC | $100.97 | 2024 | Fetroja |
| Novo Nordisk INC | $95.26 | 2025 | Wegovy |
| Harmony Biosciences LLC | $80.46 | 2021 | |
| Merck Sharp & Dohme LLC | $28.62 | 2025 | |
| Ets Wound Care LLC | $27.18 | 2025 | Mirragen Advanced Wound Matrix |
| Zoll Respicardia, INC. | $19.87 | 2024 | Remede System |
| Organogenesis INC. | $15.19 | 2025 | Apligraf |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Prity Vaidya listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.